228 related articles for article (PubMed ID: 29174174)
1. Significant association of rheumatoid arthritis-related inflammatory markers with non-surgical periodontal therapy.
Yang NY; Wang CY; Chyuan IT; Wu KJ; Tu YK; Chang CW; Hsu PN; Kuo MY; Chen YW
J Formos Med Assoc; 2018 Nov; 117(11):1003-1010. PubMed ID: 29174174
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis.
Cetinkaya B; Guzeldemir E; Ogus E; Bulut S
J Periodontol; 2013 Jan; 84(1):84-93. PubMed ID: 22414257
[TBL] [Abstract][Full Text] [Related]
3. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors.
Ortiz P; Bissada NF; Palomo L; Han YW; Al-Zahrani MS; Panneerselvam A; Askari A
J Periodontol; 2009 Apr; 80(4):535-40. PubMed ID: 19335072
[TBL] [Abstract][Full Text] [Related]
4. Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis.
Cosgarea R; Tristiu R; Dumitru RB; Arweiler NB; Rednic S; Sirbu CI; Lascu L; Sculean A; Eick S
Clin Oral Investig; 2019 Jan; 23(1):141-151. PubMed ID: 29589156
[TBL] [Abstract][Full Text] [Related]
5. Periodontal Treatment for Chronic Periodontitis With Rheumatoid Arthritis.
Thilagar S; Theyagarajan R; Mugri MH; Bahammam HA; Bahammam SA; Bahammam MA; Yadalam PK; Raj AT; Bhandi S; Patil S
Int Dent J; 2022 Dec; 72(6):832-838. PubMed ID: 35810012
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study.
Duarte PM; da Rocha M; Sampaio E; Mestnik MJ; Feres M; Figueiredo LC; Bastos MF; Faveri M
J Periodontol; 2010 Jul; 81(7):1056-63. PubMed ID: 20192617
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
[TBL] [Abstract][Full Text] [Related]
9. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis.
Kobayashi T; Okada M; Ito S; Kobayashi D; Ishida K; Kojima A; Narita I; Murasawa A; Yoshie H
J Periodontol; 2014 Jan; 85(1):57-67. PubMed ID: 23489234
[TBL] [Abstract][Full Text] [Related]
10. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein.
Shimada Y; Komatsu Y; Ikezawa-Suzuki I; Tai H; Sugita N; Yoshie H
J Periodontol; 2010 Aug; 81(8):1118-23. PubMed ID: 20370420
[TBL] [Abstract][Full Text] [Related]
11. Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients.
Konopka L; Pietrzak A; Brzezińska-Błaszczyk E
J Periodontal Res; 2012 Dec; 47(6):681-8. PubMed ID: 22510045
[TBL] [Abstract][Full Text] [Related]
12. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients.
Erciyas K; Sezer U; Ustün K; Pehlivan Y; Kisacik B; Senyurt SZ; Tarakçioğlu M; Onat AM
Oral Dis; 2013 May; 19(4):394-400. PubMed ID: 22998534
[TBL] [Abstract][Full Text] [Related]
13. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis.
Kaur S; Bright R; Proudman SM; Bartold PM
Semin Arthritis Rheum; 2014 Oct; 44(2):113-22. PubMed ID: 24880982
[TBL] [Abstract][Full Text] [Related]
14. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial.
Bazyar H; Gholinezhad H; Moradi L; Salehi P; Abadi F; Ravanbakhsh M; Zare Javid A
Inflammopharmacology; 2019 Feb; 27(1):67-76. PubMed ID: 30328031
[TBL] [Abstract][Full Text] [Related]
15. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study.
Kaushik R; Yeltiwar RK; Pushpanshu K
J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331
[TBL] [Abstract][Full Text] [Related]
16. The effects of non-surgical periodontal therapy on oxidant and anti-oxidant status in smokers with chronic periodontitis.
Akpinar A; Toker H; Ozdemir H; Bostanci V; Aydin H
Arch Oral Biol; 2013 Jun; 58(6):717-23. PubMed ID: 23261252
[TBL] [Abstract][Full Text] [Related]
17. Local and serum levels of adipokines in patients with obesity after periodontal therapy: one-year follow-up.
Gonçalves TE; Zimmermann GS; Figueiredo LC; Souza Mde C; da Cruz DF; Bastos MF; da Silva HD; Duarte PM
J Clin Periodontol; 2015 May; 42(5):431-9. PubMed ID: 25858047
[TBL] [Abstract][Full Text] [Related]
18. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
[TBL] [Abstract][Full Text] [Related]
19. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis.
Gümüş P; Nizam N; Lappin DF; Buduneli N
J Periodontol; 2014 Feb; 85(2):270-80. PubMed ID: 23701482
[TBL] [Abstract][Full Text] [Related]
20. Periodontitis and Endothelial Dysfunction: Periodontal Clinical Parameters and Levels of Salivary Markers Interleukin-1β, Tumor Necrosis Factor-α, Matrix Metalloproteinase-2, Tissue Inhibitor of Metalloproteinases-2 Complex, and Nitric Oxide.
Moura MF; Navarro TP; Silva TA; Cota LOM; Soares Dutra Oliveira AM; Costa FO
J Periodontol; 2017 Aug; 88(8):778-787. PubMed ID: 28492359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
